SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer - Khongkow, M; Olmos, Y; Gong, C; Gomes, AR; Monteiro, LJ; Yaguee, E; Cavaco, TB; Khongkow, P; Man, EPS; Laohasinnarong, S; Koo, C-Y; Harada-Shoji, N; et al. (CARCINOGENESIS, 2013)